<p>Levels of total serum cholesterol in FH/FDB heterozygotes in different age groups before lipid-lowering therapy is started are plotted against age of the subjects (data from <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0016721#pone-0016721-t001" target="_blank">Table 1</a>). Linear regression (y = 0.111x +7.408) has been used to generate the relationship between levels of total serum cholesterol and age from birth until the age of 60. Cholesterol-years scores for subjects who are put on lipid-lowering therapy at different decades and achieved a total serum cholesterol level of 5.4 mmol/l, are indicated.</p
BACKGROUND: The total cholesterol concentration decreases with age in older people. The reasons f...
The risk of premature cardiovascular disease in patients with familial hypercholesterolemia (FH) can...
Coronary heart disease remains the leading cause of death in the United States and increased blood c...
<p>Lipid-lowering therapy in subjects with FH or FDB of different age groups at the follow-up.</p
Objectives: Elevated blood cholesterol is a modifiable risk factor for cardiovascular disease. Chol...
Objectives Elevated blood cholesterol is a modifiable risk factor for cardiovascular disease. Chole...
An elevation of serum cholesterol has been one of the more frequently cited risk factors for coronar...
Familial hypercholesterolemia (FH) is a common, genetic, autosomal dominant condition, resulting in ...
The objective of this study was to examine the tracking of serum cholesterol and lipoprotein levels ...
<p>The points depict the mean total cholesterol and the vertical lines 95% confidence intervals (CI)...
In the heterozygous form of familial hypercholesterolemia (FH), blood concentrations of low-density ...
Aims Homozygous familial hypercholesterolaemia (FH) is a rare inherited disorder characterized by ex...
To study whether subjects with a molecular genetic diagnosis of familial hypercholesterolemia (FH) o...
Background: The increased risk of cardiovascular disease in familial hypercholesterolemia (FH) is ca...
The risk of premature cardiovascular disease in patients with familial hypercholesterolemia (FH) can...
BACKGROUND: The total cholesterol concentration decreases with age in older people. The reasons f...
The risk of premature cardiovascular disease in patients with familial hypercholesterolemia (FH) can...
Coronary heart disease remains the leading cause of death in the United States and increased blood c...
<p>Lipid-lowering therapy in subjects with FH or FDB of different age groups at the follow-up.</p
Objectives: Elevated blood cholesterol is a modifiable risk factor for cardiovascular disease. Chol...
Objectives Elevated blood cholesterol is a modifiable risk factor for cardiovascular disease. Chole...
An elevation of serum cholesterol has been one of the more frequently cited risk factors for coronar...
Familial hypercholesterolemia (FH) is a common, genetic, autosomal dominant condition, resulting in ...
The objective of this study was to examine the tracking of serum cholesterol and lipoprotein levels ...
<p>The points depict the mean total cholesterol and the vertical lines 95% confidence intervals (CI)...
In the heterozygous form of familial hypercholesterolemia (FH), blood concentrations of low-density ...
Aims Homozygous familial hypercholesterolaemia (FH) is a rare inherited disorder characterized by ex...
To study whether subjects with a molecular genetic diagnosis of familial hypercholesterolemia (FH) o...
Background: The increased risk of cardiovascular disease in familial hypercholesterolemia (FH) is ca...
The risk of premature cardiovascular disease in patients with familial hypercholesterolemia (FH) can...
BACKGROUND: The total cholesterol concentration decreases with age in older people. The reasons f...
The risk of premature cardiovascular disease in patients with familial hypercholesterolemia (FH) can...
Coronary heart disease remains the leading cause of death in the United States and increased blood c...